{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T02:35:48Z","timestamp":1764729348912,"version":"3.46.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["8240101442"],"award-info":[{"award-number":["8240101442"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC3402700"],"award-info":[{"award-number":["2023YFC3402700"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-025-06685-4","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T03:26:08Z","timestamp":1761017168000},"page":"5891-5903","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The heterogeneity of thoracic Castleman disease: implications for classification and personalized management"],"prefix":"10.1007","volume":"104","author":[{"given":"Yuansheng","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junkan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiahao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaowen","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junzhen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianyong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"issue":"23","key":"6685_CR1","doi-asserted-by":"publisher","first-page":"6039","DOI":"10.1182\/bloodadvances.2020003334","volume":"4","author":"F van Rhee","year":"2020","unstructured":"van Rhee F, Oksenhendler E, Srkalovic G, Voorhees P, Lim M, Dispenzieri A et al (2020) International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease. Blood Adv 4(23):6039\u20136050. https:\/\/doi.org\/10.1182\/bloodadvances.2020003334","journal-title":"Blood Adv"},{"issue":"16","key":"6685_CR2","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1182\/blood.2019000931","volume":"135","author":"A Dispenzieri","year":"2020","unstructured":"Dispenzieri A, Fajgenbaum DC (2020) Overview of Castleman disease. Blood 135(16):1353\u20131364. https:\/\/doi.org\/10.1182\/blood.2019000931","journal-title":"Blood"},{"issue":"6","key":"6685_CR3","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1111\/bjh.13378","volume":"169","author":"Y Dong","year":"2015","unstructured":"Dong Y, Wang M, Nong L, Wang L, Cen X, Liu W et al (2015) Clinical and laboratory characterization of 114 cases of Castleman disease patients from a single centre: paraneoplastic pemphigus is an unfavourable prognostic factor. Br J Haematol 169(6):834\u2013842. https:\/\/doi.org\/10.1111\/bjh.13378","journal-title":"Br J Haematol"},{"issue":"20","key":"6685_CR4","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1182\/blood-2018-07-862334","volume":"132","author":"F van Rhee","year":"2018","unstructured":"van Rhee F, Voorhees P, Dispenzieri A, Fossa A, Srkalovic G, Ide M et al (2018) International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease. Blood 132(20):2115\u20132124. https:\/\/doi.org\/10.1182\/blood-2018-07-862334","journal-title":"Blood"},{"issue":"12","key":"6685_CR5","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1182\/blood-2016-10-746933","volume":"129","author":"DC Fajgenbaum","year":"2017","unstructured":"Fajgenbaum DC, Uldrick TS, Bagg A, Frank D, Wu D, Srkalovic G et al (2017) International, evidence-based consensus diagnostic criteria for HHV-8-negative\/idiopathic multicentric Castleman disease. Blood 129(12):1646\u20131657. https:\/\/doi.org\/10.1182\/blood-2016-10-746933","journal-title":"Blood"},{"issue":"10","key":"6685_CR6","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.clml.2020.05.002","volume":"20","author":"TH Beckham","year":"2020","unstructured":"Beckham TH, Yang JC, Chau KW, Noy A, Yahalom J (2020) Excellent outcomes with surgery or radiotherapy in the management of Castleman disease including a case of oligocentric disease. Clin Lymphoma Myeloma Leuk 20(10):685\u2013689. https:\/\/doi.org\/10.1016\/j.clml.2020.05.002","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"6685_CR7","doi-asserted-by":"publisher","unstructured":"Keller AR, Hochholzer L, Castleman B (1972) Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer 29(3):670\u2013683. https:\/\/doi.org\/10.1002\/1097-0142(197203)29:3%3C670::aid-cncr2820290321%3E3.0.co;2-#","DOI":"10.1002\/1097-0142(197203)29:3%3C670::aid-cncr2820290321%3E3.0.co;2-#"},{"issue":"6","key":"6685_CR8","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/modpathol.2013.202","volume":"27","author":"KC Chang","year":"2014","unstructured":"Chang KC, Wang YC, Hung LY, Huang WT, Tsou JH (2014) Monoclonality and cytogenetic abnormalities in hyaline vascular Castleman disease. Mod Pathol 27(6):823\u2013831. https:\/\/doi.org\/10.1038\/modpathol.2013.202","journal-title":"Mod Pathol"},{"issue":"11","key":"6685_CR9","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1182\/blood.V78.11.2923.2923","volume":"78","author":"MB Leger-Ravet","year":"1991","unstructured":"Leger-Ravet MB, Peuchmaur M, Devergne O, Audouin J, Raphael M, Van Damme J et al (1991) Interleukin-6 gene expression in castleman\u2019s disease. Blood 78(11):2923\u20132930","journal-title":"Blood"},{"issue":"2","key":"6685_CR10","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/ajh.24242","volume":"91","author":"N Iwaki","year":"2016","unstructured":"Iwaki N, Fajgenbaum DC, Nabel CS, Gion Y, Kondo E, Kawano M et al (2016) Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman disease. Am J Hematol 91(2):220\u2013226. https:\/\/doi.org\/10.1002\/ajh.24242","journal-title":"Am J Hematol"},{"issue":"4","key":"6685_CR11","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1097\/SLA.0b013e318249dcdc","volume":"255","author":"N Talat","year":"2012","unstructured":"Talat N, Belgaumkar AP, Schulte KM (2012) Surgery in castleman\u2019s disease: a systematic review of 404 published cases. Ann Surg 255(4):677\u2013684. https:\/\/doi.org\/10.1097\/SLA.0b013e318249dcdc","journal-title":"Ann Surg"},{"issue":"3","key":"6685_CR12","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1159\/000049070","volume":"90","author":"M Mandreoli","year":"2002","unstructured":"Mandreoli M, Casanova S, Vianelli N, Pasquali S, Zucchelli P (2002) Remission of nephrotic syndrome due to AA amyloidosis and initiation of glomerular repair after surgical resection of localized castleman\u2019s disease. Nephron 90(3):336\u2013340. https:\/\/doi.org\/10.1159\/000049070","journal-title":"Nephron"},{"issue":"6","key":"6685_CR13","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1093\/icvts\/ivab297","volume":"34","author":"S Wang","year":"2022","unstructured":"Wang S, Chen Z, Zhang K, Tan L, Ge D, Qi F et al (2022) Individualized surgical treatment for patients with tumours of the cervicothoracic junction. Interact Cardiovasc Thorac Surg 34(6):1024\u20131030. https:\/\/doi.org\/10.1093\/icvts\/ivab297","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"2","key":"6685_CR14","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205\u2013213. https:\/\/doi.org\/10.1097\/01.sla.0000133083.54934.ae","journal-title":"Ann Surg"},{"issue":"1","key":"6685_CR15","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000521288","volume":"91","author":"ME Charlson","year":"2022","unstructured":"Charlson ME, Carrozzino D, Guidi J, Patierno C (2022) Charlson comorbidity index: A critical review of clinimetric properties. Psychother Psychosom 91(1):8\u201335. https:\/\/doi.org\/10.1159\/000521288","journal-title":"Psychother Psychosom"},{"issue":"1","key":"6685_CR16","doi-asserted-by":"publisher","first-page":"8694","DOI":"10.1038\/s41598-022-12797-y","volume":"12","author":"XQ Wang","year":"2022","unstructured":"Wang XQ, Zhong NN, Sun Q, Yan SC, Xu GC, Wang YG et al (2022) Comprehensive analysis of 65 patients with Castleman disease in a single center in China. Sci Rep 12(1):8694. https:\/\/doi.org\/10.1038\/s41598-022-12797-y","journal-title":"Sci Rep"},{"issue":"11","key":"6685_CR17","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1002\/ajh.23291","volume":"87","author":"A Dispenzieri","year":"2012","unstructured":"Dispenzieri A, Armitage JO, Loe MJ, Geyer SM, Allred J, Camoriano JK et al (2012) The clinical spectrum of castleman\u2019s disease. Am J Hematol 87(11):997\u20131002. https:\/\/doi.org\/10.1002\/ajh.23291","journal-title":"Am J Hematol"},{"issue":"1","key":"6685_CR18","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1182\/asheducation-2018.1.318","volume":"2018","author":"DC Fajgenbaum","year":"2018","unstructured":"Fajgenbaum DC (2018) Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease. Hematol Am Soc Hematol Educ Program 2018(1):318\u2013. https:\/\/doi.org\/10.1182\/asheducation-2018.1.318. 25","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"1","key":"6685_CR19","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/s41572-021-00317-7","volume":"7","author":"A Carbone","year":"2021","unstructured":"Carbone A, Borok M, Damania B, Gloghini A, Polizzotto MN, Jayanthan RK et al (2021) Castleman disease. Nat Rev Dis Primers 7(1):84. https:\/\/doi.org\/10.1038\/s41572-021-00317-7","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"6685_CR20","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/bjh.15019","volume":"180","author":"E Oksenhendler","year":"2018","unstructured":"Oksenhendler E, Boutboul D, Fajgenbaum D, Mirouse A, Fieschi C, Malphettes M et al (2018) The full spectrum of Castleman disease: 273 patients studied over 20 years. Br J Haematol 180(2):206\u2013216. https:\/\/doi.org\/10.1111\/bjh.15019","journal-title":"Br J Haematol"},{"issue":"4","key":"6685_CR21","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1093\/ajcp\/99.4.385","volume":"99","author":"J Krishnan","year":"1993","unstructured":"Krishnan J, Danon AD, Frizzera G (1993) Reactive lymphadenopathies and atypical lymphoproliferative disorders. Am J Clin Pathol 99(4):385\u2013396. https:\/\/doi.org\/10.1093\/ajcp\/99.4.385","journal-title":"Am J Clin Pathol"},{"issue":"10","key":"6685_CR22","doi-asserted-by":"publisher","first-page":"4451","DOI":"10.1172\/JCI126091","volume":"129","author":"DC Fajgenbaum","year":"2019","unstructured":"Fajgenbaum DC, Langan RA, Japp AS, Partridge HL, Pierson SK, Singh A et al (2019) Identifying and targeting pathogenic PI3K\/AKT\/mTOR signaling in IL-6-blockade-refractory idiopathic multicentric Castleman disease. J Clin Invest 129(10):4451\u20134463. https:\/\/doi.org\/10.1172\/JCI126091","journal-title":"J Clin Invest"},{"issue":"6","key":"6685_CR23","doi-asserted-by":"publisher","first-page":"734","DOI":"10.24875\/RMIMSS.M20000107","volume":"58","author":"S Sanchez-Pardo","year":"2020","unstructured":"Sanchez-Pardo S, Rojas-Holguin DF, Choi-Park I, Osorio-Ramirez JA, Bolivar-Mejia A (2020) [TAFRO syndrome, variant of castleman\u2019s disease: case report]. Rev Med Inst Mex Seguro Soc 58(6):734\u2013739. https:\/\/doi.org\/10.24875\/RMIMSS.M20000107","journal-title":"Rev Med Inst Mex Seguro Soc"},{"issue":"12","key":"6685_CR24","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.2337\/dc08-1034","volume":"31","author":"J Mitri","year":"2008","unstructured":"Mitri J, Castillo J, Pittas AG (2008) Diabetes and risk of Non-Hodgkin\u2019s lymphoma: a meta-analysis of observational studies. Diabetes Care 31(12):2391\u20132397. https:\/\/doi.org\/10.2337\/dc08-1034","journal-title":"Diabetes Care"},{"issue":"1","key":"6685_CR25","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.diabet.2019.04.006","volume":"46","author":"Y Wang","year":"2020","unstructured":"Wang Y, Liu X, Yan P, Bi Y, Liu Y, Zhang ZJ (2020) Association between type 1 and type 2 diabetes and risk of non-Hodgkin\u2019s lymphoma: A meta-analysis of cohort studies. Diabetes Metab 46(1):8\u201319. https:\/\/doi.org\/10.1016\/j.diabet.2019.04.006","journal-title":"Diabetes Metab"},{"issue":"1","key":"6685_CR26","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/s41467-023-36225-5","volume":"14","author":"JM Gammon","year":"2023","unstructured":"Gammon JM, Carey ST, Saxena V, Eppler HB, Tsai SJ, Paluskievicz C et al (2023) Engineering the lymph node environment promotes antigen-specific efficacy in type 1 diabetes and islet transplantation. Nat Commun 14(1):681. https:\/\/doi.org\/10.1038\/s41467-023-36225-5","journal-title":"Nat Commun"},{"issue":"8","key":"6685_CR27","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1097\/CM9.0000000000001795","volume":"135","author":"X Chen","year":"2022","unstructured":"Chen X, Chen Y, Li T, Liang W, Huang H, Su H et al (2022) Diabetes mellitus promoted lymph node metastasis in gastric cancer: a 15-year single-institution experience. Chin Med J (Engl) 135(8):950\u2013961. https:\/\/doi.org\/10.1097\/CM9.0000000000001795","journal-title":"Chin Med J (Engl)"},{"issue":"3","key":"6685_CR28","doi-asserted-by":"publisher","first-page":"285","DOI":"10.4093\/dmj.2020.0250","volume":"45","author":"AMY Zhang","year":"2021","unstructured":"Zhang AMY, Wellberg EA, Kopp JL, Johnson JD (2021) Hyperinsulinemia in Obesity, Inflammation, and cancer. Diabetes Metab J 45(3):285\u2013311. https:\/\/doi.org\/10.4093\/dmj.2020.0250","journal-title":"Diabetes Metab J"},{"issue":"12","key":"6685_CR29","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1016\/j.cmet.2023.10.003","volume":"35","author":"AMY Zhang","year":"2023","unstructured":"Zhang AMY, Xia YH, Lin JSH, Chu KH, Wang WCK, Ruiter TJJ et al (2023) Hyperinsulinemia acts via acinar insulin receptors to initiate pancreatic cancer by increasing digestive enzyme production and inflammation. Cell Metab 35(12):2119\u201335e5. https:\/\/doi.org\/10.1016\/j.cmet.2023.10.003","journal-title":"Cell Metab"},{"issue":"1","key":"6685_CR30","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1182\/bloodadvances.2020003607","volume":"5","author":"MY Zhang","year":"2021","unstructured":"Zhang MY, Jia MN, Chen J, Feng J, Cao XX, Zhou DB et al (2021) UCD with MCD-like inflammatory state: surgical excision is highly effective. Blood Adv 5(1):122\u2013128. https:\/\/doi.org\/10.1182\/bloodadvances.2020003607","journal-title":"Blood Adv"},{"issue":"5","key":"6685_CR31","first-page":"850","volume":"112","author":"JL Seco","year":"1992","unstructured":"Seco JL, Velasco F, Manuel JS, Serrano SR, Tomas L, Velasco A (1992) Retroperitoneal castleman\u2019s disease. Surgery 112(5):850\u2013855","journal-title":"Surgery"},{"issue":"5","key":"6685_CR32","first-page":"474","volume":"46","author":"GR Post","year":"2016","unstructured":"Post GR, Bell RC, Rjoop A, Lobo RH, Yuan Y, Post SR (2016) Diagnostic utility of Interleukin-6 expression by immunohistochemistry in differentiating Castleman disease subtypes and reactive lymphadenopathies. Ann Clin Lab Sci 46(5):474\u2013479","journal-title":"Ann Clin Lab Sci"},{"key":"6685_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfma.2024.09.038","author":"YC Lee","year":"2024","unstructured":"Lee YC, Lu CW, Hsieh MS, Hsu HH (2024) Clinicopathological characteristics of unicentric Castleman disease: A single-center experience of 12 patients. J Formos Med Assoc. https:\/\/doi.org\/10.1016\/j.jfma.2024.09.038","journal-title":"J Formos Med Assoc"},{"key":"6685_CR34","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12890-015-0019-x","volume":"15","author":"JM Luo","year":"2015","unstructured":"Luo JM, Li S, Huang H, Cao J, Xu K, Bi YL et al (2015) Clinical spectrum of intrathoracic Castleman disease: a retrospective analysis of 48 cases in a single Chinese hospital. BMC Pulm Med 15:34. https:\/\/doi.org\/10.1186\/s12890-015-0019-x","journal-title":"BMC Pulm Med"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06685-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-025-06685-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06685-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T02:31:37Z","timestamp":1764729097000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-025-06685-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":34,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["6685"],"URL":"https:\/\/doi.org\/10.1007\/s00277-025-06685-4","relation":{},"ISSN":["1432-0584"],"issn-type":[{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2025,10,21]]},"assertion":[{"value":"2 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Zhongshan Hospital (B2025-100). Written informed consent was obtained from all participants prior to their involvement in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}